000			01620nam a2200277 4500
001			384318
010			_a9291681229
090			_a384318
100			_a20070531d2002 y0pory50 ba
101			_aeng
200			_aReport on the risk assessment of GHB in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d2002
215			_a92 p. _d21 cm
330			_aForeword. Abbreviations. Introduction. report on the risk assessment of GBH in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risks of GHB. Public health risks of GHB - epidemiological evidence. References. Participants in the risk-assessment process.
606			_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892
606			_aRELATÓRIO _9410454
606			_aDROGA SINTÉTICA _9320915
606			_aCOOPERAÇÃO INTERNACIONAL _9229150
606			_aOEDT _9321506
606			_aEMCDDA _9324041
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta